These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 12957641)

  • 1. Evaluation of the swelling, hydration and rupturing properties of the swelling layer of a rupturable pulsatile drug delivery system.
    Bussemer T; Peppas NA; Bodmeier R
    Eur J Pharm Biopharm; 2003 Sep; 56(2):261-70. PubMed ID: 12957641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. pH-independent pulsatile drug delivery system based on hard gelatin capsules and coated with aqueous dispersion Aquacoat ECD.
    Mohamad A; Dashevsky A
    Eur J Pharm Biopharm; 2006 Oct; 64(2):173-9. PubMed ID: 16814532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation parameters affecting the performance of coated gelatin capsules with pulsatile release profiles.
    Bussemer T; Bodmeier R
    Int J Pharm; 2003 Nov; 267(1-2):59-68. PubMed ID: 14602384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of a pulsatile release drug delivery system using different swellable/rupturable materials.
    El-Maradny HA
    Drug Deliv; 2007 Nov; 14(8):539-46. PubMed ID: 18027184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Process and formulation variables affecting the performance of a rupturable capsule-based drug delivery system with pulsatile drug release.
    Dashevsky A; Bussemer T; Mohamad A; Bodmeier R
    Drug Dev Ind Pharm; 2004 Feb; 30(2):171-9. PubMed ID: 15089051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of pulsatile multiparticulate drug delivery system coated with aqueous dispersion Aquacoat ECD.
    Mohamad A; Dashevsky A
    Int J Pharm; 2006 Aug; 318(1-2):124-31. PubMed ID: 16759827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pulsatile drug delivery system based on rupturable coated hard gelatin capsules.
    Bussemer T; Dashevsky A; Bodmeier R
    J Control Release; 2003 Dec; 93(3):331-9. PubMed ID: 14644583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and mathematical simulation of theophylline pulsatile release tablets.
    Zhu Y; Zheng L
    Drug Dev Ind Pharm; 2005 Dec; 31(10):1009-17. PubMed ID: 16316857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of pulsatile release tablets with swelling and rupturable layers.
    Sungthongjeen S; Puttipipatkhachorn S; Paeratakul O; Dashevsky A; Bodmeier R
    J Control Release; 2004 Mar; 95(2):147-59. PubMed ID: 14980764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulsatile drug delivery to ileo-colonic segments by structured incorporation of disintegrants in pH-responsive polymer coatings.
    Schellekens RC; Stellaard F; Mitrovic D; Stuurman FE; Kosterink JG; Frijlink HW
    J Control Release; 2008 Dec; 132(2):91-8. PubMed ID: 18775755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enteric-coating of pulsatile-release HPC capsules prepared by injection molding.
    Macchi E; Zema L; Maroni A; Gazzaniga A; Felton LA
    Eur J Pharm Sci; 2015 Apr; 70():1-11. PubMed ID: 25585355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymeric coatings for a multiple-unit pulsatile delivery system: preliminary study on free and applied films.
    Maroni A; Del Curto MD; Cerea M; Zema L; Foppoli A; Gazzaniga A
    Int J Pharm; 2013 Jan; 440(2):256-63. PubMed ID: 22688248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of hydroxypropyl methylcellulose matrix systems as swellable gastro-retentive drug delivery systems (GRDDS).
    Matharu AS; Motto MG; Patel MR; Simonelli AP; Dave RH
    J Pharm Sci; 2011 Jan; 100(1):150-63. PubMed ID: 20572054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release characteristics and in vitro-in vivo correlation of pulsatile pattern for a pulsatile drug delivery system activated by membrane rupture via osmotic pressure and swelling.
    Lin HL; Lin SY; Lin YK; Ho HO; Lo YW; Sheu MT
    Eur J Pharm Biopharm; 2008 Sep; 70(1):289-301. PubMed ID: 18539015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo evaluation of an oral multiple-unit formulation for colonic delivery of insulin.
    Maroni A; Del Curto MD; Salmaso S; Zema L; Melocchi A; Caliceti P; Gazzaniga A
    Eur J Pharm Biopharm; 2016 Nov; 108():76-82. PubMed ID: 27519826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simulation and evaluation of rupturable coated capsules by finite element method.
    Yang Y; Fang J; Shen L; Shan W
    Int J Pharm; 2017 Mar; 519(1-2):220-229. PubMed ID: 28109897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and in vitro evaluation of an enteric-coated multiparticulate drug delivery system for the administration of piroxicam to dogs.
    Debunne A; Vervaet C; Remon JP
    Eur J Pharm Biopharm; 2002 Nov; 54(3):343-8. PubMed ID: 12445566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual coating of swellable and rupturable polymers on glipizide loaded MCC pellets for pulsatile delivery: formulation design and in vitro evaluation.
    Yadav D; Survase S; Kumar N
    Int J Pharm; 2011 Oct; 419(1-2):121-30. PubMed ID: 21807081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Studies on preparation of isosorbide-5-mononitrate pulsatile controlled-release pellets and various influence factors].
    Wang R; Huang G; Fang Z
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Aug; 25(4):885-8. PubMed ID: 18788301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards elucidation of the drug release mechanism from compressed hydrophilic matrices made of cellulose ethers. II. Evaluation of a possible swelling-controlled drug release mechanism using dimensionless analysis.
    Ferrero C; Massuelle D; Doelker E
    J Control Release; 2010 Jan; 141(2):223-33. PubMed ID: 19766681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.